For the third quarter of fiscal 2025, the company expects revenues of $4.65 billion (+/- $300 million). The Zacks Consensus Estimate is pegged at $4.64 billion, indicating 22.3% growth from the figure ...

Lockdowns, lab closures, funding cuts, and delays to ongoing clinical trials have all contributed to cancer research disruptions that may set the field back two years, according to new estimates made ...

The sun and wind are not anytime and anywhere available, so how do you temporarily store that energy? A group of researchers at Eindhoven University of Technology sees a dream candidate in metal fuels ...

Lam Research Corporation LRCX is scheduled to release its third-quarter fiscal 2025 results on April 23. The Zacks Consensus Estimate for earnings is pegged at $1 per share, calling for growth of 28.2 ...